Employees Area
Therapeutic Areas

Martin Dow has three major business segments which foster our corporate vision of becoming a leading pharmaceutical company of the region ensuring accessibility of high quality healthcare products to the society. These segments are strategically aligned to bring innovative, high-quality and affordable medicines including:

  • Licensed products from world renowned partners like ROCHE – Switzerland, Tiejin – Japan and Biocodex – France.
  • Acquired brands from ROCHE – Switzerland, MEDA PharmaGmbH – Sweden and Riemser PharmaGmbH – Germany.
  • Locally manufactured generics at our cGMP compliant manufacturing facility.

Martin Dow develops and markets innovative medicines to enhance health outcomes for patients and health care providers. We are at the forefront of development and commercialization of primary care and specialty medicines comprising of different therapeutic segments and specialties:

  • Anti-Infectives
  • Neuropsychiatry
  • Rheumatology and Orthopedics
  • Pain Management
  • Pediatrics
  • Gastroenterology
  • Cardiology
  • Endocrinology and Diabetes
  • Dermatology

NEW SEGMENTS

Martin Dow Ltd. has continued to focus towards the development of the company not only through the provision of quality centric medicines and services, but it has also taken up the responsibility to provide the same quality to a greater variety of its customers. For that purpose, Martin Dow is incessantly endeavoring to enter into new markets.

Martin Dow’s enabling mindset and pro-active approach has recently enabled it to enter the following markets:

 

  • Cosmaceutical
  • Oncology
  • Vaccines
  • Dentistry
  • Nutraceuticals and Dietary supplements

Facebook

News & Media

  • Top Pharmaceutical Companies Supplement
    Top Pharmaceutical Companies Supplement
    (October 26, 2017)

    Read More
  • The Swiss Confederation Day Supplement
    The Swiss Confederation Day Supplement
    (October 26, 2017)

    Read More
  • Bastille Day Supplement
    Bastille Day Supplement
    (October 26, 2017)

    Read More
  • Martin Dow announces the National Consensus Guidelines for Chemoprophylaxis & Surgical Site Infections
    Martin Dow announces the National Consensus Guidelines for Chemoprophylaxis & Surgical Site Infections
    (August 3, 2017)

    Read More
  • Martin Dow in talks to buy French biotech firm
    Martin Dow in talks to buy French biotech firm
    (April 12, 2017)

    Read More
  • Martin Dow Pharmaceuticals Inauguration : Meymac France
    Martin Dow Pharmaceuticals Inauguration : Meymac France
    (March 24, 2017)

    Read More
  • World Osteoporosis Day Radio Program
    World Osteoporosis Day Radio Program
    (February 6, 2017)

    Read More
  • Martin Dow-Biocodex to supply Enflor
    Martin Dow-Biocodex to supply Enflor
    (January 18, 2017)

    Read More
  • TerraBiz to hold first M&A moot on December 7
    TerraBiz to hold first M&A moot on December 7
    (January 18, 2017)

    Read More
  • French President to inaugurate Pakistani Pharma Plant in France
    French President to inaugurate Pakistani Pharma Plant in France
    (January 18, 2017)

    Read More
  • Martin Dow acquires Merck operations in Pakistan
    Martin Dow acquires Merck operations in Pakistan
    (January 18, 2017)

    Read More
  • World Mental Health Day
    World Mental Health Day
    (December 22, 2016)

    Read More
  • France Trade & Investment Report 2016
    France Trade & Investment Report 2016
    (July 14, 2016)

    Read More
  • Serving the changing world
    Serving the changing world
    (November 16, 2015)

    Read More
  • Martin Dow setting up clinic for IBA students
    Martin Dow setting up clinic for IBA students
    (November 14, 2015)

    Read More
  • Awarding Dr. Ishrat Hussain
    Awarding Dr. Ishrat Hussain
    (August 31, 2015)

    Read More
  • Martin Dow and quality healthcare go together
    Martin Dow and quality healthcare go together
    (July 14, 2015)

    Read More
  • Martin Dow donates Rs 1 million to IBA
    Martin Dow donates Rs 1 million to IBA
    (April 4, 2015)

    Read More
  • MD Biocodex sign deal
    MD Biocodex sign deal
    (February 26, 2015)

    Read More